
關(guān)注公眾號
了解更多
作者: 發(fā)布時間:2023-06-02 17:19:24點擊:891
1st
藥物相互作用研究技術(shù)指導(dǎo)原則(試行)(2021年1月)
2nd
U.S. Department of Health and Human Services Food and Drug Administration
Center for Drug Evaluation and Research (CDER)
In Vitro Drug Interaction Studies —Cytochrome P450 Enzyme- and Transporter-Mediated Drug Interactions Guidance for Industry(January 2020 Clinical Pharmacology)
3rd
Shujun Fu , Feifei Yu , Zhuohan Hu Tao Sun
Metabolism-mediated drug–drug interactions – Study design, data analysis, and implications for in vitro evaluations
4th
Shujun Fu , Feifei Yu , Tao Sun , Zhuohan Hu
Transporter-mediated drug–drug interactions – Study design, data analysis,and implications for in vitro evaluations
5th
Watanabe,T., Kusuhara,H., Maeda,K., Kanamaru,H., Saito,Y., Hu,Z. and Sugiyama,Y.
Investigation of the rate-determining process in the hepatic elimination of HMG-CoA reductase inhibitors in rats and humans. Drug Metab. Dispos. 2010, 38, 215-222
6th
Bent H. Hellum, Zhuohan Hu, Odd Georg Nilsen
The Induction of CYP1A2, CYP2D6 and CYP3A4 by Six Trade Herbal Products in Cultured Primary Human Hepatocytes. Basic & Clinical Pharmacology & Toxicology. 2007, 100: 23-30
7th
Takao Watanabe, Hiroyuki Kusuhara, Tomoko Watanabe, Yasuyuki Debori, Kazuya Maeda, Tsunenori Kondo, Hideki Nakayama, Shigeru Horita, Brian W. Ogilvie, Andrew Parkinson, Zhuohan Hu and Yuichi Sugiyama
Prediction of the overall renal tubular secretion and hepatic clearance of anionic drugs and a renal drug-drug interaction involving OAT3 in humans by in vitro uptake experiments. Drug Metab. Dispos.2011,39: 1031-1038.
8th
Wakaba Yamashiro, Kazuya Maeda, Masakazu Hirouchi, Yasuhisa Adachi, Zhuohan Hu,and Yuichi Sugiyama
Involvement of transporters in the hepatic uptake and biliary excretion of valsartan, a selective antagonist II AT-receptor, in humans. Drug Metab. Dispos. 2006, 37, 1247 - 1254